Why rising GLP-1 costs aren’t going away and what to do about it. Read more in the HDMS case study.
HDMS Case Study: Three Cost Containment Strategies for GLP-1 Drugs
Latest Posts
Partner News
Segal Benz: Creating a Workplace Culture of Support for Better Mental Health
Take the Moment for Mental Health This year’s Mental Health Awareness Month theme is Take the Moment. ...
Read More
Partner News
Benefex: Transforming Benefits Administration with Global Tech Solutions
There are a whole host of strategic and tactical reasons why organizations look to a ...
Read More
Partner News
WTW: Beyond Open Enrollment – How AI is Revolutionizing Benefits Throughout the Year
Using generative AI applications for open enrollment and improved benefits experience year-round Generative AI, driven ...
Read More